1Boiselair MD, Lane DA,Philippou H, et al. Thrombin Prednction,inactivation and expression during open heart surgery measured by assays for activation fragments including a newELISA for prothrombin Fragment F1.2. Thromb Haemost, 1993,70:253-258.
2Blister SJ, Ofosn FA, Buchanan MR. Thrombin generatioa during cardiac surgery Is heparin the ideal anticoag.
3Stone Sr, Hofsteenge J. Kinetics of the inhibtion of thrombin by hirudin Biochem, 1986,2.5:4622-4628.
4Talbot M. Biology of recombinant hirudin( CGP39393 ) :a new prospoc in the treatment of thrombosis sore. Thromb Hoemost, 1989,15: 293-301.
5Marki WF, Wallis RB. The anticoagulant and antithrombotie prop-erties of hirudins. Thromb Haemost, 1990,61:344-348.
6Wachtforgel Y, Kucich U, Hack CE, et al. Aprotinin inhibits the contact, neutrophil, andplatelet activation systems during simulated cxtacorporal perfu-gion. Jthorac Cardiovaasc Surg, 1993,106 : 1-10.
7Zoldhelyi P,Webater MWI, Fucter V, et al. Recombinant hinudin in palieuls will chronic stablc coronary artery dicaese. Circulation, 1993,88:2015-2022.
8Lindhout T, Blezer R, Hemker HC. The anticoagulant mechanismof action of recombinant hirudin( CGP 39393 )in plasma. Thromb haemost, 1990,64:464-468.
9Olson ST, Bjork I. Predominant contibution of surface approxi-mation to thrombin reaction. J Biol Chem, 1991,266:6353-6362.
